Trade Mark Journal No.2025/021 23 May 2025
WO0000001841416 (9,42,44)
Office of origin: United States of America
Date of International Registration:27 August 2024
Date of designation in the UK:
27 August 2024

International priority date claimed: 27 February 2024
(United States of America)
(98423746)
- Class 9
- Downloadable computer software platforms for drug development; downloadable computer software platforms for use in the field of oncology for disease detection and treatment; downloadable computer software platforms for cancer detection.
- Class 42
- Providing online non-downloadable computer software platforms for drug development; providing online non-downloadable computer software platforms for use in the field of oncology for disease detection and treatment; providing online non-downloadable computer software platforms for cancer detection; scientific research; pharmaceutical research services; medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals.
- Class 44
- Medical diagnostic services in the field of cancer; medical services, namely, cancer detection; diagnostic services for use in the treatment and diagnosis of cancer.
Harbinger Health, Inc.
Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA